Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients

Poppelaars, F.; Costa, M.G. da; Faria, B.; Berger, S.P.; Assa, S.; Daha, M.R.; ... ; Seelen, M.A. (2018)

Article / Letter to editor

• complement
• kidney
• cardiovascular risk
• hemodialysis
• biocompatibility
• innate immunity
• C1-inhibitor

• All authors: Poppelaars, F.; Costa, M.G. da; Faria, B.; Berger, S.P.; Assa, S.; Daha, M.R.; Pestana, J.O.M.; Son, W.J. van; Franssen, C.F.M.; Seelen, M.A.
• Date: 2018-09-13
• Journal: Frontiers in Immunology
• Volume: 9
• DOI: doi:10.3389/fimmu.2018.02070
• Link: https://www.frontiersin.org/articles/10.3389/fimmu.2018.02070/full